CONTINUOUS SUBCUTANEOUS INFUSION OF HYOSCINE BUTYLBROMIDE REDUCES SECRETIONS IN PATIENTS WITH GASTROINTESTINAL OBSTRUCTION

被引:61
作者
DECONNO, F
CARACENI, A
ZECCA, E
SPOLDI, E
VENTAFRIDDA, V
机构
[1] Pain Therapy and Palliative Care Division, National Cancer Institute, Milan
关键词
HYOSCINE BUTYLBROMIDE; MALIGNANT GI-OBSTRUCTION; GI-SECRETIONS;
D O I
10.1016/0885-3924(91)90005-O
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We describe the use of hyoscine butylbromide as a subcutaneous infusion in 3 patients with inoperable malignant bowel obstruction. An objective reduction of drainage from the gastrointestinal tract was observed with the hyoscine butylbromide infusion (60-120 mg/day). We suggest that this effect can be useful in the palliative treatment of vomiting in inoperable bowel obstruction.
引用
收藏
页码:484 / 486
页数:3
相关论文
共 10 条
[1]  
Baines, Oliver, Carter, Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and patholological study, Lancet, 2, pp. 990-993, (1985)
[2]  
Oliver, The use of the syringe driver in terminal care, Br J Clin Pharmacol, 20, pp. 515-516, (1985)
[3]  
Ventafridda, Ripamonti, Caraceni, Spoldi, Messina, De Conno, The management of inoperable gastrointestinal obstruction in terminal cancer patients, Tumori, 76, pp. 389-393, (1990)
[4]  
Bauer, Gross, Scarselli, Stockhaus, Wick, Uber Wirkungsunterchiede von Atropin, Scopolamin und einigen ihren quartaren Derivate nach subcutaner und enteralen Gabe unter besonderer Berucksichtigung des Scopolamin-n-butylbromids, Arzneimittel Forschung, 18, pp. 1132-1137, (1968)
[5]  
Weiner, Atropine, scopolamine and related antimuscarinic drugs, The pharmacological basis of therapeutics, pp. 120-137, (1980)
[6]  
Gespach, Emami, Chastre, Membrane receptors in the gastrointestinal tract, Bioscience Reports, 43, pp. 199-232, (1988)
[7]  
Giraldo, Martos, Gomes, Et al., Characterization of muscarinic receptor subtypes in human tissues, Life Sci, 43, pp. 1507-1515, (1988)
[8]  
Herxeimeer, Haefeli, Human pharmacology of hyoscine butylbromide, The Lancet, 2, pp. 418-421, (1966)
[9]  
Lloret, Munoz, Monmany, Et al., Treatment of renal colic with dypirone, Curr Ther Res, 42, pp. 1119-1128, (1987)
[10]  
Grosskopf, Die alternative Therapie der Gallenkolik, Z Allg Med, 64, pp. 723-726, (1988)